The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

Over the past 13 years bone marrow‐derived mononuclear cells (BM‐MNCs) have been widely investigated for clinical efficacy in patients following acute myocardial infarction (AMI). These early phase II trials have used various surrogate markers to judge efficacy and, although promising, the results h...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Anthony, Arnold, Roman, Assmus, Birgit, Bartunek, Jozef, Belmans, Ann, Bönig, Halvard, Crea, Filippo, Dimmeler, Stefanie, Dowlut, Sheik, Fernández‐Avilés, Francisco, Galiñanes, Manuel, Garcia‐Dorado, David, Hartikainen, Juha, Hill, Jonathan, Hogardt‐Noll, Annette, Homsy, Christian, Janssens, Stefan, Kala, Petr, Kastrup, Jens, Martin, John, Menasche, Philippe, Miklik, Roman, Mozid, Abdul, San Román, J. Alberto, Sanz‐Ruiz, Ricardo, Tendera, Michal, Wojakowski, Wojtek, Ylä‐Herttuala, Seppo, Zeiher, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
New Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607485/
https://www.ncbi.nlm.nih.gov/pubmed/28948706
http://dx.doi.org/10.1002/ejhf.829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607485/
https://www.ncbi.nlm.nih.gov/pubmed/28948706
http://dx.doi.org/10.1002/ejhf.829

Ejemplares similares